Ministry of Industry and Trade of Russia developed a draft resolution that will toughen the restrictions on the admission of foreign medicinal products for purchases under No. 44-FZ. At present, such restrictions are established by the decree of the government of the Russian Federation of November 30, 2015 No. 1289 in the form of a “third extra” rule. When purchasing products from the list of vital and essential medicinal products, the customer is obliged to reject all other applications containing foreign goods if there are at least two among them with an offer of goods from the EAEU countries (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Russia) from different manufacturers.
The draft of the Ministry of Industry and Trade contains a list of 15 medicinal products, upon the purchase of which the customer will reject all applications with foreign goods if at least one participant offers goods from the EAEU countries (the rule is “the second is superfluous”).
Public discussion of the project was held on the government website until December 3. 2935 votes were cast for him, and 2551 were against. An hour before the end of the voting, the site went wrote journalist Katerina Gordeeva. Because of this, many opponents of the bill were unable to vote at a time when the gap was only 300 votes.
Gordeeva calls the adoption of the bill a disaster. “Of course, among the Russian (Armenian, Belarusian, Kazakh and Kyrgyz) drug manufacturers there are those who make high-quality generics, but they are not small and understand very well how many high-quality foreign drugs we are now going to lose. And who and what of the patients of our country will pay for the support of the domestic manufacturer, which is carried out not by creating a healthy competitive environment, but by eliminating the choice of patients and doctors, ”she stressed.
Import substitution of drugs makes it difficult to treat rare diseases using modern protocols. For example, in the treatment of a rare genetic disease, cystic fibrosis, modern antibiotics are needed to combat concomitant infections. In recent years, hospitals have been using domestic counterparts, selected on the basis of the “extra third” principle.
In early December, the RF IC reported on the initiation of a criminal case in the Nizhny Novgorod region after the death of a 10-year-old girl with cystic fibrosis. The parents of a sick child received from the state only a basic set of medicines, but not vital and expensive antibiotics and medical equipment.
The girl’s mother filed a lawsuit against the regional Ministry of Health and won the court. However, officials were in no hurry to comply with the court’s decision. They said that the budget for the current year has been exhausted, and the medicine can only be purchased in February 2022, which the girl did not live to see.